Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sildenafil topical - Dare Bioscience/Strategic Science and Technologies

Next Previous
Drug Profile

Sildenafil topical - Dare Bioscience/Strategic Science and Technologies

Alternative Names: Sildenafil citrate cream 5%; Sildenafil citrate topical cream (5%); Sildenafil cream (3.6%); Sildenafil cream 3.6%; SST-6007; Topical 5% sildenafil citrate cream

Latest Information Update: 16 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Strategic Science & Technologies
  • Developer Dare Bioscience; Strategic Science & Technologies
  • Class Antihypertensives; Erectile dysfunction therapies; Phenyl ethers; Piperazines; Purines; Pyrazoles; Pyrimidinones; Small molecules; Sulfonamides
  • Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Female sexual dysfunction

Most Recent Events

  • 31 Mar 2025 Dare Bioscience plans to make Sildenafil topical cream available by prescription in the fourth quarter of 2025 through a 503B compounding pathway
  • 16 Dec 2024 Dare Biosciences plans a phase III trial in Female sexual dysfunction (Topical) in the mid year 2025
  • 26 Aug 2024 Updated efficacy data from the phase IIb RESPOND trial in Female sexual dysfunction by Dare Bioscience

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top